We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALYA
4126
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$0 ﹤0.01%
136
+80
+143% +$203
SRC
4127
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-1,164
Closed -$57K
SALM
4128
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
-500
Closed -$1K
ONCT
4129
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$0 ﹤0.01%
2
-20
-91% -$1.49K
LTHM
4130
DELISTED
Livent Corporation
LTHM
$0 ﹤0.01%
+59
New +$496
HALL
4131
DELISTED
Hallmark Financial Services, Inc.
HALL
-246
Closed -$44K
RPT
4132
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-80
Closed -$1K
FTCH
4133
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-14,715
Closed -$152K
SGEN
4134
DELISTED
Seagen Inc. Common Stock
SGEN
-29
Closed -$3K
CORR
4135
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-280
Closed -$13K
HEP
4136
DELISTED
Holly Energy Partners, L.P.
HEP
-2,235
Closed -$50K
GHL
4137
DELISTED
Greenhill & Co., Inc.
GHL
-330
Closed -$6K
AVTA
4138
DELISTED
Avantax, Inc. Common Stock
AVTA
-78
Closed -$2K
LHC.U
4139
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
-120
Closed -$1K
ARGO
4140
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-641
Closed -$42K
AVID
4141
DELISTED
Avid Technology Inc
AVID
-3,577
Closed -$31K
CEQP
4142
DELISTED
Crestwood Equity Partners LP
CEQP
-2,638
Closed -$81K
RVLP
4143
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$0 ﹤0.01%
217
-11,001
-98% -$58.6K
EMAN
4144
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
80
HCCI
4145
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-66
Closed -$2K
ZYNE
4146
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-4,250
Closed -$26K
CEN
4147
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$0 ﹤0.01%
4
+1
+33% +$48
SYNH
4148
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-8,567
Closed -$510K
SNLN
4149
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
-100
Closed -$2K
INFI
4150
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-11,829
Closed -$11K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.